Mesothelioma | Mesothelioma

... Three Cryoablation Studies Presented at Society of Interventional Radiology Annual Meeting Three Cryoablation Studies Presented at Society of Interventional Radiology Annual Meeting Early Data From One Study Suggest Combination of Cryotherapy and Immunotherapy Agent May Have Systemic Immune Effect on Metastases in Mice With Metastatic Cancer IRVINE, Calif., March 31 /PRNewswire-FirstCall/ - Endocare, Inc.

(OTC Bulletin Board: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today that three clinical papers related to the Company's cryoablation technology will be presented at the Society of Interventional Radiology (SIR) 2006 Annual Meeting held in Toronto from March 30 through April 4.

Stephen Solomon, MD, Associate Member, Department of Radiology, Memorial Sloan-Kettering Cancer Center and presenting author on the three studies said, "Taken together with the growing body of data in existence, the three abstracts presented at SIR indicate that when properly administered cryoablation is an effective ablative technique for renal, lung and liver tumors, as long as protocols are tailored to the patient and tumor and patient selection guidelines are optimized.

It is also interesting that our animal work suggests that although cryoablation only physically treats the specific tumor site targeted, in combination with immunotherapy agents, th...

Read more...